|
|
||||||||
Articles |
1
Bone Metabolic Unit and
2
Department of Clinical Chemistry, Scientific Institute H San Raffaele, Via Olgettina 60, 20132 Milan, Italy.
a Address correspondence to this author at: Unita' Metabolica dell' Osso, Istituto Scientifico San Raffaele, Via Olgettina 60, I-20132 Milan, Italy. Fax 39-02-26433038; e-mail a.rubinacci{at}hsr.it
Background: Deoxypyridinoline (Dpd) is one of the two pyridinium cross-links that provide structural rigidity to type I collagen in bone. During osteoclastic resorption, Dpd is released into circulation and is excreted in the urine in free and peptide-bound forms. Free and total Dpd are highly correlated, but whether the free-to-total cross-link ratio is constant in both normal and high bone turnover states remains controversial. To compare free and total Dpd performance in a physiological condition, urinary free and total Dpd were measured after a short-term inhibition of osteoclast activity such as that induced by an oral calcium load.
Methods: Total and free Dpd were measured by HPLC and by immunosorbent assay, respectively, in two groups of subjects, one (calcium-treated; n = 16) taking calcium and the other not (control; n = 9).
Results: The urinary excretion of total Dpd at 2 and 4 h after oral calcium loading was decreased compared with controls. By contrast, changes in free Dpd were similar in the calcium-treated and control groups, reflecting only circadian rhythm.
Conclusions: Total and free Dpd do not show comparable sensitivity in detecting short-term inhibition of osteoclast activity. The degradation process of peptide-bound to free Dpd could render free Dpd insensitive to acute changes of osteoclast activity.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. Karkkainen, C. J. Lamberg-Allardt, S. Ahonen, and M. Valimaki Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism Am. J. Clinical Nutrition, September 1, 2001; 74(3): 335 - 342. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |